The impact of intestinal complications on health care costs among inflammatory bowel disease patients treated with anti-tumor necrosis factor therapies

Abstract     Authors: David T Rubin, Jenny Griffith, Qisu Zhang, Zsolt Hepp, Allison Keshishian Background: Although there is evidence that anti-tumor necrosis factor (TNF) utilization earlier in the inflammatory bowel disease (IBD) course and before the...